DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), announced today the filing of a patent infringement lawsuit by Amarin affiliates and a licensor against Hikma Pharmaceuticals PLC and Hikma’s U.S. affiliate. The lawsuit was filed in the United States District Court in Delaware. […]
Financial
Zimmer Biomet Completes Acquisition of A&E Medical Corporation
Deal Adds Innovative Solutions and Establishes High-Growth Market Leadership for Zimmer Biomet WARSAW, Ind., Dec. 1, 2020 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the company has completed the acquisition of A&E Medical Corporation, a Vance Street Capital Portfolio Company, for $150 […]
VivaLNK Appoints Jennifer Esposito to Board of Directors
Veteran in Healthcare industry to advise VivaLNK’s executive team and assist in its growth in the Digital Health space CAMPBELL, Calif., Dec. 1, 2020 /PRNewswire/ — VivaLNK, a leading provider of connected healthcare solutions known for its unique medical wearable sensor platform and vitals data service, announces today that Jennifer Esposito joins its Board of […]
Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business
MARLBOROUGH, Mass., Dec. 1, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Stark International Lux S.A.R.L., and SERB SAS, affiliates of SERB, a European specialty pharmaceutical group, to sell its BTG Specialty Pharmaceuticals business for $800 million in cash. SERB, backed by private equity firm […]
Matinas BioPharma Appoints Hui Liu, Ph.D., M.B.A. as Chief Technology Officer
– Dr. Liu brings more than 20 years of expertise in pharmaceutical development, formulation, and CMC, with specific focus on lipid-based delivery of complex molecules – BEDMINSTER, N.J., Dec. 01, 2020 (GLOBE NEWSWIRE) — Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to […]
Jim Andrews Appointed to Biome Analytics Board
Cardiovascular service line executive brings 10 years of senior leadership experience and a proven track record of value creation SAN FRANCISCO–(BUSINESS WIRE)–Biome Analytics, the leading cardiovascular performance company announced that they have expanded the Board of Directors with the appointment of Jim Andrews. Andrews is currently senior vice president, cardiac […]
Bayer and Blackford Analysis Announce AI Platform Agreement in Radiology
Bayer and Blackford Analysis have entered into a development and license agreement to establish an artificial intelligence (AI) platform for medical imaging. This agreement supports Bayer’s commitment to expanding its AI capabilities and accelerating innovation in radiology INDIANOLA, Pa.–(BUSINESS WIRE)–During the week of November 29 to December 5, leaders in […]
Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer
RESEARCH TRIANGLE PARK, N.C., Nov. 30, 2020 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced Michael Kaseta has been appointed Chief Financial Officer (CFO), effective immediately. He succeeds Steve Bariahtaris who has served as Liquidia’s interim CFO since August 2020. Mr. Bariahtaris has agreed to provide assistance to the […]
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
KYOTO, Japan, Nov. 24, 2020 /PRNewswire/ — OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram (ECG) technology. OMRON led this round of investment, reinforcing the cross-company collaboration that began in 2017. The companies continue to […]
Medtronic Reports Second Quarter Fiscal 2021 Financial Results
– Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic – Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2021, which ended October 30, 2020. The company reported second quarter worldwide revenue of $7.647 billion, […]
Recent
Medtronic completes acquisition of Scientia Vascular, seamlessly integrating access and therapeutic portfolios for neurovascular care
Penumbra’s THUNDERBOLT Receives FDA Clearance – Bringing Computer Assisted Vacuum Thrombectomy Technology to Stroke
Spectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology
Popular
- No commented posts yet